Melanie L. Conrad

Dr. Melanie L. Conrad

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
MCMelanie L. Conrad
Melanie L. Conrad
RFRuth Ferstl
Ruth Ferstl
RTRené Teich
René Teich
SBStephanie Brand
Stephanie Brand
NBNicole Blümer
Nicole Blümer
RHRenz Harald
Renz Harald
The pre- and postnatal environment may represent a window of opportunity for allergy and asthma prevention, and the hygiene hypothesis implies that microbial agents may play an important role in this regard. Using the cowshed-derived bacterium Acinetobacter lwoffii F78 together with a mouse model of experimental allergic airway inflammation, this study investigated the hygiene hypothesis, maternal (prenatal) microbial exposure, and the involvement of Toll-like receptor (TLR) signaling in prenatal protection from asthma. Maternal intranasal exposure to A. lwoffii F78 protected against the development of experimental asthma in the progeny. Maternally, A. lwoffii F78 exposure resulted in a transient increase in lung and serum proinflammatory cytokine production and up-regulation of lung TLR messenger RNA. Conversely, suppression of TLRs was observed in placental tissue. To investigate further, the functional relevance of maternal TLR signaling was tested in TLR2/3/4/7/9−/− knockout mice. The asthma-preventive effect was completely abolished in heterozygous offspring from A. lwoffii F78–treated TLR2/3/4/7/9−/− homozygous mother mice. Furthermore, the mild local and systemic inflammatory response was also absent in these A. lwoffii F78–exposed mothers. These data establish a direct relationship between maternal bacterial exposures, functional maternal TLR signaling, and asthma protection in the progeny.

19 March 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MUMatteo Ugolini
Matteo Ugolini
JGJenny Gerhard
Jenny Gerhard
SBSanne Burkert
Sanne Burkert
KJKristoffer Jarlov Jensen
Kristoffer Jarlov Jensen
PGPhilipp Georg
Philipp Georg
LSLeif E. Sander
Leif E. Sander

24 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SNSandra Nolte
Sandra Nolte
RORichard Osborne
Richard Osborne
SDSarah Dwinger
Sarah Dwinger
GEGerald R Elsworth
Gerald R Elsworth
MCMelanie L. Conrad
Melanie L. Conrad
JZJördis M Zill
Jördis M Zill
The Health Literacy Questionnaire (HLQ), developed in Australia in 2012 using a ‘validity-driven’ approach, has been rapidly adopted and is being applied in many countries and languages. It is a multidimensional measure comprising nine distinct domains that may be used for surveys, needs assessment, evaluation and outcomes assessment as well as for informing service improvement and the development of interventions. The aim of this paper is to describe the German translation of the HLQ and to present the results of the validation of the culturally adapted version. The HLQ comprises 44 items, which were translated and culturally adapted to the German context. This study uses data collected from a sample of 1,058 persons with chronic conditions. Statistical analyses include descriptive and confirmatory factor analyses. In one-factor congeneric models, all scales demonstrated good fit after few model adjustments. In a single, highly restrictive nine-factor model (no cross-loadings, no correlated errors) replication of the original English-language version was achieved with fit indices and psychometric properties similar to the original HLQ. Reliability for all scales was excellent, with a Cronbach’s Alpha of at least 0.77. High to very high correlations between some HLQ factors were observed, suggesting that higher order factors may be present. Our rigorous development and validation protocol, as well as strict adaptation processes, have generated a remarkable reproduction of the HLQ in German. The results of this validation provide evidence that the HLQ is robust and can be recommended for use in German-speaking populations. Trial Registration: German Clinical Trial Registration (DRKS): DRKS00000584. Registered 23 March 2011.

9 July 2009 in Clinical & Experimental Allergy
Verified
Journal Article
Open access
PDF file
MCMelanie L. Conrad
Melanie L. Conrad
AYAli Önder Yildirim
Ali Önder Yildirim
SSS. S. Sonar
S. S. Sonar
AKA. Kılıç
A. Kılıç
SSS. Sudowe
S. Sudowe
HGHolger Garn
Holger Garn
Summary: Introduction The most widely used protocol for the induction of experimental allergic airway inflammation in mice involves sensitization by intraperitoneal (i.p.) injections of the antigen ovalbumin (OVA) used in conjunction with the adjuvant aluminium hydroxide (alum). Although adjuvants are frequently used, there are questions regarding the necessity of alum for murine asthma studies due to the non‐physiological nature of this chemical.Objective The objective of this study was to compare experimental asthma phenotypes between adjuvant and adjuvant‐free protocols of murine allergic airway inflammation in an attempt to develop a standardized alternative to adjuvant use.Method An adjuvant‐free OVA model of experimental asthma was investigated in BALB/c mice using i.p. or subcutaneous (s.c.) sensitization routes. For the s.c. sensitization, β‐galactosidase (β‐gal) was also tested as an antigen. In addition, OVA adjuvant and adjuvant‐free sensitization protocols were compared in BALB/c and C57BL/6 mice. Open‐field testing was performed to assess the effect of alum on mouse behaviour.Results Comparison of adjuvant vs. adjuvant‐free and i.p. vs. s.c. protocols revealed that both adjuvant use and route of antigen application significantly influenced OVA‐specific antibody production. Comparison of adjuvant and adjuvant‐free protocols in this study clearly demonstrated the non‐requirement of alum for the induction of acute allergic airway inflammation, as both protocols induce a similar disease phenotype. BALB/c mice were significantly more susceptible than C57BL/6 mice to sensitization. Using the improved s.c. adjuvant‐free protocol, it was demonstrated that alternative antigens such as β‐gal can also be utilized. Behavioural studies indicated severe distress in mice treated with alum.Conclusion The OVA s.c. adjuvant‐free protocol used in this study generates a phenotype comparable to the benchmark adjuvant protocol widely used in the literature. The adjuvant‐free alternative avoids the added complication of non‐physiological adjuvants that may interfere with asthma treatment or prevention strategies.

16 February 2020 in Allergy
Verified
Journal Article
Open access
PDF file
MAMoumen M. Alhasan
Moumen M. Alhasan
ACAlissa M. Cait
Alissa M. Cait
Heimesaat MarkusHeimesaat Markus
Heimesaat Markus
MBMichael Blaut
Michael Blaut
RKRobert Klopfleisch
Robert Klopfleisch
MCMelanie L. Conrad
Melanie L. Conrad
Background: The use of antibiotics during pregnancy is associated with increased allergic asthma risk in the offspring, and given that approximately 25% of pregnant women are prescribed antibiotics, it is important to understand the mechanisms contributing to this phenomenon. Currently, there are no studies that directly test this association experimentally. Our objective was to develop a mouse model in which antibiotic treatment during pregnancy results in increased offspring asthma susceptibility.Methods: Pregnant mice were treated daily from gestation day 8‐17 with an oral solution of the antibiotic vancomycin, and three concentrations were tested. At weaning, offspring were subjected to an adjuvant‐free experimental asthma protocol using ovalbumin as an allergen. The composition of the gut microbiome was determined in mothers and offspring with samples collected from five different time points; short‐chain fatty acids were also analyzed in allergic offspring.Results: We found that maternal antibiotic treatment during pregnancy was associated with increased offspring asthma severity in a dose‐dependent manner. Furthermore, maternal vancomycin treatment during pregnancy caused marked changes in the gut microbiome composition in both mothers and pups at several different time points. The increased asthma severity and intestinal microbiome changes in pups were also associated with significantly decreased cecal short‐chain fatty acid concentrations.Conclusion: Consistent with the “Developmental Origins Hypothesis,” our results confirm that exposure to antibiotics during pregnancy shapes the neonatal intestinal environment and increases offspring allergic lung inflammation.

27 September 2024 in Allergy
Verified
Journal Article
Open access
MCMelanie L. Conrad
Melanie L. Conrad
GBGabriela Barrientos
Gabriela Barrientos
XCXuejun Cai
Xuejun Cai
SMSaikat Mukherjee
Saikat Mukherjee
MDMrinmoy Das
Mrinmoy Das
Hani HarbHani Harb
Hani Harb
The incidence of allergic diseases has been rising over the past decades, and this troubling trend coincides with environmental changes such as shifts in diet and increased antibiotic use, both of which can impact our immune system. Allergic reactions occur when the immune system overreacts to normally harmless substances, and it is known that regulatory T cells (Tregs) play a major role in immune system suppression and the generation of tolerance. However, new research suggests that Tregs can malfunction in environments that promote allergies. This review delves into Treg function, and how environmental factors can influence their ability to maintain immune homeostasis. Specifically, we explore the origins of Treg cells, as well as the mechanisms used for suppression of inflammation and tissue healing, with a concentration on food allergies, atopic dermatitis and asthma. Understanding Treg function in the context of a changing environment is crucial for developing new strategies to prevent and treat allergies.